A novel disease mechanism leading to the expression of a disallowed gene in the pancreatic beta-cell identified by non-coding, regulatory mutations controlling HK1
View ORCID ProfileMatthew N. Wakeling, Nick D. L. Owens, Jessica R. Hopkinson, Matthew B. Johnson, Jayne A.L. Houghton, Antonia Dastamani, Christine S. Flaxman, Rebecca C. Wyatt, Thomas I. Hewat, Jasmin J. Hopkins, View ORCID ProfileThomas W. Laver, Rachel Van Heugten, Michael N. Weedon, Elisa De Franco, View ORCID ProfileKashyap A. Patel, Sian Ellard, Noel G. Morgan, Edmund Cheesman, Indraneel Banerjee, View ORCID ProfileAndrew T. Hattersley, Mark J. Dunne, International Congenital Hyperinsulinism Consortium, Sarah J. Richardson, View ORCID ProfileSarah E. Flanagan
doi: https://doi.org/10.1101/2021.12.03.21267240
